Loading market dashboard
Impel Pharmaceuticals Inc.
IMPLHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Impel Pharmaceuticals Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2025 | $160.00M | $160.00M - $160.00M | $0.00 | $0.85 | 1 |
| Dec 2024 | $50.90M | $50.90M - $50.90M | $0.00 | -$0.87 | 1 |
| Dec 2023 | $28.70M | $28.70M - $28.70M | $0.00 | -$1.58 | 1 |
| Dec 2022 | $12.65M | $12.65M - $12.65M | $0.00 | -$4.12 | 0 |
| Dec 2021 | $1.80M | $1.80M - $1.80M | $0.00 | -$1.34 | 0 |